Surgery
Volume 146, Issue 6 , Pages 1006-1013 , December 2009

The long-term benefit of parathyroidectomy in primary hyperparathyroidism: A 10-year prospective surgical outcome study

  • Janice L. Pasieka, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Janice L. Pasieka, MD, Faculty of Medicine, University of Calgary, Department of Surgery, North Tower, 1403 29th Street NW, Calgary, Alberta T2N 2T9, Canada.
    • ,
  • Louise Parsons, MSc
    • ,
  • Jean Jones

,Accepted 5 October 2009.

References 

  1. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:2275–2285
  2. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351–365
  3. Solomon BL, Schaaf M, Smallridge RC. Psychologic symptoms before and after parathyroid surgery. Am J Med. 1994;96:101–106
  4. Prager G, Kalaschek A, Kaczirek K, Passler C, Scheuba C, Sonneck G, et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery. 2002;132:930–936
  5. Joborn C, Hetta J, Johansson H, Rastad J, Agren H, Akerström G, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988;12:476–481
  6. Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007;13:338–344
  7. Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005;242:642–650
  8. Bilezikian JP, Khan AA, Potts JT. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–339
  9. Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:366–372
  10. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462–3470
  11. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery. 2003;134:675–3
  12. Mihai R, Sadler GP. Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg. 2008;32:807–814
  13. Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh Q, Clark O. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism. Are they too limited?. Ann Surg. 2004;239:528–535
  14. Greutelaers B, Kullen K, Kollias J, Bochner M, Roberts A, Wittert G, et al. Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg. 2004;74:112–115
  15. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, et al. A patient-based surgical outcome tool demonstrating improvement of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26:942–949
  16. Pasieka JL, Parsons LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg. 1998;22:513–518
  17. Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism?. Surgery. 2002;132:1013–1020
  18. Bilezikian JP, Potts JT, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353–5361
  19. Chan AK, Duh Q, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperthyroidism before and after parathyroidectomy. Ann Surg. 1995;222:402–412
  20. Lundgren E, Ljunghall S, Akerstrom G, Hetta J, Malmaeus J, Rastad J. Case-control study on symptoms and signs of ‘asymptomatic’ primary hyperparathyroidism. Surg. 1998;124:980–986
  21. Hasse C, Sitter H, Bachmann S, Zielke A, Koller M, Nies C, et al. How asymptomatic is asymptomatic primary hyperparathyroidism?. Exp Clin Endocrinol Diabetes. 2000;108:265–274
  22. Burney RE, Jones KR, Peterson M, Christy B, Thompson NW. Surgical correction of primary hyperparathyroidism improves quality of life. Surg. 1998;124:987–999
  23. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89:5415–5422
  24. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92:1687–1692
  25. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92:3114–3121

 Presented at AAES 2009.

 Support for this study was provided through the Endocrine Surgical Research Foundation in the Department of Surgery, University of Calgary.

PII: S0039-6060(09)00631-X

doi: 10.1016/j.surg.2009.10.021

Surgery
Volume 146, Issue 6 , Pages 1006-1013 , December 2009

Article Tools